Victrex (OTCMKTS:VTXPF) Lowered to “Hold” Rating by Barclays

Victrex (OTCMKTS:VTXPF) was downgraded by equities research analysts at Barclays from a “strong-buy” rating to a “hold” rating in a report issued on Wednesday,Zacks.com reports.

Separately, Morgan Stanley reiterated an “overweight” rating on shares of Victrex in a research report on Wednesday, October 15th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Victrex Stock Performance

OTCMKTS VTXPF opened at $9.78 on Wednesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.58 and a current ratio of 3.81. Victrex has a twelve month low of $8.99 and a twelve month high of $13.24. The stock’s 50-day simple moving average is $9.78 and its two-hundred day simple moving average is $9.86.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.